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Abstract
Background: Various studies have shown the deleterious effect of high volume resuscitation following severe
trauma promoting coagulopathy by haemodilution, acidosis and hypothermia. As the optimal resuscitation strategy
during prehospital trauma care is still discussed, we raised the question if the amount and kind of fluids
administered changed over the recent years. Further, if less volume was administered, fewer patients should have
arrived in coagulopathic depletion in the Emergency Department resulting in less blood product transfusions.
Methods: A data analysis of the 100 489 patients entered into the TraumaRegister DGU® (TR-DGU) between 2002
and 2012 was performed of which a total of 23512 patients (23.3 %) matched the inclusion criteria. Volume and
type of fluids administered as well as outcome parameter were analysed.
Results: Between 2002 and 2012, the amount of volume administered during prehospital trauma care decreased
from 1790 ml in 2002 to 1039 ml in 2012. At the same time higher haemoglobin mean values, higher Quick’s mean
values and reduced mean aPTT can be observed. Simultaneously, more patients received catecholamines (2002: 9.2
to 2012: 13.0 %). Interestingly, the amount of volume administered decreased steadily regardless of the presence of
shock. Fewer patients were in the need of blood products and the number of massive transfusions (≥10 pRBC)
more than halved.
Discussion: The changes in volume therapy might have reduced haemodilution potentially resulting in an increase
of the Hb value. During the period observed transfusion strategies have become more restrictiveand ratio based;
the percentage of patients receiving MT halved as blood products may imply negative secondary effects.
Furthermore, preventing administration of high blood product ratios result in less impairment of coagulation factors
and inhibitors and an therfore improved coagulation.
Conclusion: The volume administered in severely injured patients decreased considerably during the last decade
possibly supporting beneficial effects such as minimizing the risk of coagulopathy and avoiding potential harmful
effects caused by blood product transfusions. Despite outstanding questions in trauma resuscitation, principle
evidence merges quickly into clinical practice and algorithms.
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Background
Volume administration is one of the first therapeutic op-
tions in trauma care. While in 1993 Schwab and colleagues
[1] already adapted the US Navy expression ‘damage con-
trol’ to trauma surgery, the administration of a significant
amount of crystalloids was still common practice [2]. The
benefits of delayed fluid resuscitation in hypotensive, bleed-
ing patients were shown to improve patients’ outcome [3].
Subsequently, deleterious effects of excess crystalloid, such
as abdominal compartment syndrome, acute respiratory
distress syndrome or multiple organ failure (MOF),
aroused attention [4, 5]. Non-indicated enhanced volume
replacement therapy had furthermore been reported to be
associated with increased mortality [6, 7].
At the same time the early posttraumatic coagulopathy
has been recognized as an independent entity due to its
high incidence at the time of emergency department (ED)
admission [8–11]. In addition to endogenous triggers such
as tissue trauma, inflammation and endothelial dysfunction,
exogenous and iatrogenic factors like uncritical volume ad-
ministration which contributes to acidosis and hypothermia
(“vicious circle”) were described to enhance blood clotting
disorder massively [12].
In order to reduce the amount of crystalloids, col-
loids were commonly administered in the treatment of
haemorrhagic or septic shock. However, negative side
effects such as acute kidney injury and impaired co-
agulation were observed [13]. Therefore, even after
haemorrhage, the indication for colloids is questioned
while the European medicines agency’s Pharmacovigi-
lance Risk Assessment Committee (PRAC) inferred
from recent studies that hydroxyethyl starch solutions
(HES) must no longer be used to treat patients with
sepsis or critically illness [14, 15]. However, hypertonic
solutions are safe but do not show any benefits com-
pared to crystalloids [16, 17].
The increasing awareness of the adverse effects of an
incautious volume therapy has led to more restrained
recommendations regarding volume replacement in
pre-hospital care. Therefore, damage control princi-
ples were developed targeting a rapid control of surgi-
cal bleeding, an early use of red blood cells (RBC) and
plasma, the limitation of excessive crystalloid use and
permissive hypotension [18].
In the present study, the question is raised whether the
academic awareness “doing more with less” has led to a
reduced prehospital volume administration with balanced
electrolyte solutions and colloids in the course of the last
decade (2002–2012). Furthermore, it is investigated if an
altered volume management has improved coagulation
parameters of seriously injured patients and if consecu-
tively less blood products with its potentially harmful ef-




The TraumaRegister DGU® of the German Trauma Society
(Deutsche Gesellschaft für Unfallchirurgie, DGU) was
founded in 1993. The aim of this multi-centre database is
an anonymous and standardized documentation of severely
injured patients.
Data are collected prospectively in four consecutive time
phases from the site of the accident until dis-charge from
hospital: A) Pre-hospital phase, B) Emergency room and
initial surgery, C) Intensive care unit and D) Discharge. The
documentation includes detailed information on demo-
graphics, injury pattern, comorbidities, pre- and in-hospital
management, course on intensive care unit, relevant labora-
tory findings including data on transfusion and outcome of
each individual. The inclusion criterion is admission to
hospital via emergency room with subsequent ICU/ICM
care or reaching the hospital with vital signs and death be-
fore admission to ICU.
The infrastructure for documentation, data management,
and data analysis is provided by the AUC - Academy for
Trauma Surgery (AUC - Akademie der Unfallchirurgie
GmbH), a company affiliated to the German Trauma Soci-
ety. The scientific leadership is provided by the Committee
on Emergency Medicine, Intensive Care and Trauma Man-
agement (Sektion NIS) of the German Trauma Society. The
participating hospitals submit their data anonymously into
a central database via a web-based application. Scientific
data analysis is approved according to a peer review pro-
cedure established by Sektion NIS.
The participating hospitals are primarily located in
Germany (90 %), but a rising number of foreign hospitals
of other countries contribute data as well (at the moment
from Austria, Belgium, China, Finland, Luxembourg,
Slovenia, Switzerland, The Netherlands, and the United
Arab Emirates). Currently, approx. 25,000 cases from more
than 600 hospitals are yearly entered into the database.
Participation in TraumaRegister DGU® is voluntary.
For hospitals associated with TraumaNetzwerk DGU®,
however, the entry of at least a basic data set is obliga-
tory for quality assurance.
The present study is in line with the publication guide-
lines of the TraumaRegister DGU® and registered as TR-
DGU project ID 2013-057.
In this study, only patients from Germany were in-
cluded in order to exclude variations in pre-hospital
emergency and rescue systems among different coun-
tries. A full list of participating hospitals contributing to
the TR-DGU can be found at www.traumaregister-
dgu.de. All patients admitted were seen and treated by
an emergency physician prior to hospital admission.
nclusion criteria for this analysis were as follows:
1.) Age ≥ 18 years
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2.) ISS (Injury Severity Score) ≥ 16 points
3.) Primary admission to the hospital (transfers
excluded)
4.) Standard documentation data record TR-DGU®
5.)Hospitals participation for 5 or more years
Of the 100.489 patients entered into the data bank of
the TR-DGU 2002–2012, a total of 23512 (23.4 %)
matched with the inclusion criteria. The remaining num-
bers were excluded due to hospital transfers (n = 10989;
10.3 %), minor injuries (n = 42735; 42.5 %), injured chil-
dren below 18 years (n = 1761; 1.72 %), data points that
were edited into the short TR-DGU form (n = 15260;
15.2 %), TR-DGU participation for less than 5 years (n =
2132; 2.5 %), absence (n = 1328; 1.3 %) or unknown at-
tendance (n = 1240; 1.2 %) of an emergency physician
prior admission to the hospital and missing values
for administered fluids and/or the red blood cells
(RBCs) (n = 1532; 1.5 %). Similar to previous publica-
tions derived from the TR-DGU, shock is defined as
systolic blood pressure less or equal (≤) 90 mmHg.
Massive transfusion (MT) is specified as more or
equal than 10 units of transfused RBCs until ICU
admission. Ringer’s solution or 0.9 % NaCl are docu-
mented as crystalloid solutions; HES is documented
as colloidal solution and HyperHES as hyperoncotic
solution. Haemostatic drug therapy in the Emergency
Department (ED) was documented since 2005; previ-
ous data are also not available for aPTT. Haemo-
static drug therapy was defined as the following:
administration of Factor VII, Prothrombin Complex
Concentrate (PCC/PPSB), Fibrinogen and Tranex-
amic Acid.
Statistics
Continuous and categorical values were calculated as
overall values for the whole time period and separately for
each year. If not presented graphically for each year, over-
all values are reported together with the first (2002) and
the last (2012) value, or with the range (minimum - max-
imum) of yearly values. This retrospective analysis has a
descriptive character. Formal statistical testing comparing
all 11 years was avoided since even minor differences
would result in highly significant results, due to the large
sample size per year. However, in order to analyze poten-
tial trends and to estimate yearly changes, repeated linear
regression analyses have been performed where the vari-
able of interest was the dependent (i.e. predicted) variable,
and the year of observation was the independent (i.e. the
predictor) variable. The regression coefficient calculated
for each year could then be interpreted as the approximate
change per year. The p-value of this coefficient is
presented as well. Interpretation of these results have to
consider that this approach assumes a constant change
over the time period considered which is not always the
case.
We did not restrict our analysis to major bleeding cases
since the application of volume has been used very delib-
erately in Germany, and prophylactic use of volume ad-
ministration has been considered an easy and effective
support of severely injured patients. Volume was given to
at least 95 % of registry patients in the prehospital phase.
The average annual values and their parallel increase or
decrease over time are just observed associations, there is
no proof of causality. A formal proof of the volume effect
on lab values and transfusion rates would require a ran-
domized trial. However, these measurements were made
within a short period of time within each patient, on aver-
age within less than 1 h regarding initial lab values, and
2–3 h regarding transfusion. This would not allow to as-
sume independence of the measurements. However, the
degree of causation remains a matter of interpretation.
Data were analysed using SPSS statistical software
package (Version 21, IBM Inc., Armonk, NY, U.S.A.)
Results
A total of 23512 patients from the TR-DGU® met the in-
clusion criteria for further analysis. General demograph-
ics and injury description as well as their respective
changes per year are shown in Table 1. While most of
the trauma mechanisms did not differ during the obser-
vation period, motor vehicle accidents (MVA) decreased
from 40.4 % in 2002 to 29.7 % in 2012 whereas low falls
(<3 m) increased from 6.7 to 11.9 %. The proportion of
severe head injuries (AIS head ≥3) remained constant
while severe abdominal injuries (AIS abdomen ≥3) oc-
curred significantly less often (Table 1). The mean ISS
was 29 points and did not change over 11 years, while
the NISS increased slightly (Table 1). On scene, fewer
patients were in shock (23.1 % in 2002 vs. 17.3 % in
2012) while the number of patients in shock admitted to
ED remained constant (Fig. 1).
The analysis of the prehospital volume administration
between 2002 and 2012 showed that 22575 patients
(96.0 %; min - mix 95.0–96.9 %) received prehospital
intravenous (i.v.) fluids by the emergency physician. If
volume was given, most patients (n = 22110; 97.9 %) re-
ceived crystalloids. The use of colloids and hyperoncotic
solutions, which were usually given in combination with
crystalloids, decreased drastically over time (colloids:
69.6 % in 2002 to 28.5 % in 2012; hyperoncotic fluids:
16.4 % in 2002 to 6.0 % in 2012). In contrast, the num-
ber of patients receiving crystalloids stayed constantly
high (range 96.6 to 98.8 %) in the period presented. The
mean volume administered per year subdivided into
fluid types, respectively, is shown in Fig. 2a and Table 1.
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The average amount of total volume administered de-
creased from 1790 ml to 1039 ml (Fig. 2a). Comparing
the amount of volume administered to patients with and
without shock, a steady decrease can be observed in
both groups (Fig. 2b). As expected, more volume was
administered to patients in shock. Similar to the trend of
reduced prehospital volume administration, the volume
administered in the ED dropped from 3191 ml in 2002
to 1416 ml in 2012.
Over the time observed, the rate of trauma patients
who received prehospital catecholamines inclined from
9.2 to 13.0 %. The proportion of patients receiving cate-
cholamines at the ED stayed constantly around 30 %. At
the same time, fewer patients received RBCs (38.7 % in
2002 vs. 20.6 % in 2012; Fig. 3). If transfused, the num-
ber of RBC units administered decreased per patient by
-0.22 units per year (9.8 RBCs in 2002 vs. 7.6 in 2012).
In contrast units of fresh frozen plasma (FFPs) were
given to an equal extent, mirroring nearly a 1:1 RBC:FFP
ratio in 2012 (6,7 FFP in 2002 vs. 6,1 FFP in 2012). The
lowered administration of blood products was further
accompanied with less MT that even more than halved
(13.4 % in 2002 vs. 5.2 % in 2012). Haemoglobin and
Quick’s values increased at admission and the
Fig. 1 Percentage of patients in shock (≤90mmHG systolic blood
pressure) during the prehospital phase and by the time of arrival
in ED
Fig. 2 a Mean prehospital fluid administration in millilitres (ml) per
year for crystalloids, colloids and hypertonic solution and average
amount of volume given at the emergency department. b
Administered prehospital volume for patients depending on first
measured blood pressure (shock defined as systolic
blood pressure ≤ 90 mmHg)
Table 1 General demographics, characteristics of injury and key features of volume management and their respective change per
year
All patients Value 2002 Value 2012 Change per year p-value
Demographics Age (years; mean (min-max)) 47.0 (43.8–50.3) 43.8 50.3 0.83 <0.001
Male (%; mean (min-max)) 72.9 (71.9–74.3) 73.4 71.9 −0.2 0.11
Injury assessment Penetrating trauma (%; mean (min-max)) 4.2 (3.5–5.6) 4.2 4.2 −0.1 0.08
AIS Head ≥3 points (%; mean (min-max)) 56.0 (53.0–59.9) 55.4 53.0 −0.3 0.01
AIS Thorax ≥3 points (%; mean (min-max)) 58.9 (54.0–61.1) 59.8 59.9 −0.1 0.15
AIS Abdomen ≥3 points (%; mean (min-max)) 19.6 (17.3–25.4) 25.4 17.3 −0.9 <0.001
ISS (points; mean (min-max)) 28.9 (28.3–29.6) 28.6 28.3 −0.08 0.003
NISS (points; mean (min-max)) 35.1 (33.4–36.2) 33.6 34.6 0.04 0.001
Volume administration Total prehospital volume (ml; mean (min-max)) 1282 (1039–1790) 1790 1039 −73.7 <0.001
Prehospital crystalloid fluids (ml; mean (min-max)) 931 (1156–837) 1156 849 −30.6 <0.001
Prehospital colloid fluids (ml; mean (min-max)) 317 (169–574) 574 169 −39.3 <0.001
Prehospital hyperoncotic fluids (ml; mean (min-max)) 34.2 (20.0–59.6) 59.6 20.0 −3.5 <0.001
Total volume at ED (ml; mean (min-max)) 2030 (1345–3191) 3191 1416 −222 <0.001
Blood products RBC units/patient, all (n; mean (min-max)) 2.1 (1.6–3.8) 3.8 1.6 −0.21 <0.001
RBC units/patient, if transfused (n; mean (min-max)) 8.1 (9.8–7.4) 9.8 7.6 −0.22 <0.001
Patients with ≥1 RBC (%; mean (min-max)) 26.0 (18.1–38.7) 38.7 20.6 −2.0 <0.001
Patients receiving MT (%; mean (min-max)) 7.1 (4.8–13.4) 13.4 5.2 −0.8 <0.001
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abnormality of the mean Base Excess (BE) declined
(Fig. 4). Since the start of recording in 2005, there is a
steady rise in the use of haemostatic medication from
10.3 to 18.3 %.
Discussion
More than two decades passed by since physicians and
researchers started to realize the deleterious effects of
excessive administration of crystalloids [4, 5].
Although it is well known and taught among emergency
personnel that factors such as age >80 years, ISS ≥16,
GCS <8, hypotension and excessive administration of i.v.
fluids promote patients mortality, [19] it has not been
proven if evidence obtains clinical practice.
The period analysed in the present study includes the
point in time when rising interest and understanding
among experts in the role of hypothermia, coagulopathy
and acidosis aroused [4, 5]. Since uncritical volume
administration was identified to enhance this vicious cir-
cle, a steady decrease of the administered volume after
severe trauma can be observed in both, the prehospital
use and in ED.
Collecting data in a databank such as the TR-DGU®
enables analysis of trauma cases and therapeutic strat-
egies accordingly. As expected with an aging society, pa-
tients enclosed in this study grew 0.83 years older per
year on average for the timeframe observed, which
might at the same time explain the increased rate of low
falls below three meters. Improved road safety results in
a lower percentage of major road accidents. Neverthe-
less, also the number of high falls of more than three
meters height increased in the period observed. Despite
these changes in injury mechanisms, the mean ISS and
NISS stayed consistently high and could therefore not
cause these differences in volume management. A higher
number and a higher severity of injuries of the extrem-
ities and pelvis might equalize the decrease of AIS
abdomen.
During the last years the evidence even more mounted
that aggressive crystalloid administration rather causes a
worsening acidosis, may trigger an early inflammatory
response, and also entails an substantial increase in mor-
bidity such as Acute Respiratory Distress Syndrome
(ARDS), MOF, compartment syndromes and surgical site
infections [20, 21]. Although there is less doubt about
i.v. fluid administration in trauma patients to maintain
tissue perfusion, there is no evidence about any volume
threshold for trauma patients [22]. Among others, [23]
the PROMMTT Study Group showed that pre-hospital
fluid administration is not associated with increased sys-
tolic blood pressure but decreases in-hospital mortality
[24]. In contrast, Geeraedts et al. described, that in a co-
hort of hypotensive trauma patients, prehospital volume
therapy was associated with a decrease of the likelihood
of shock defined as shock index ≥ 1 [25]. Interestingly,
patients in this study received decisively less volume
(median, min to max: 0.5 L, 0–8.1 L) compared to our
data. The difference might be caused by the fact that
Geeraedts et al. included all hypotensive trauma pa-
tients, regardless of the injury severity. However, this
study underlies the importance of cautious pre-hospital
volume replacement.
Furthermore, HAES should not be used in most cases
except therapy refractory haemorrhagic shock and pos-
sibly penetrating trauma due to less renal affection and
decreased lactate levels [26]. Unfortunately, information
about the type and concentration of Hydroxyethyl starch
are not available, in order to accomplish a more detailed
analysis. However, according to the recommendations,
we can clearly file the reduced over all use in our data.
In comparison of the three different fluids administered
the most notable reduction can be seen in colloids.
Although fewer patients were in shock on scene and
the prehospital treatment differed decisively, the rate of
Fig. 3 Percentage of patients receiving ≥1 RBC and massive
transfusions (≥10 RBC’s within 24 h) per year
Fig. 4 Laboratory results in first blood analysis. a Hb and Quick’s
value by the time of arrival in the emergency department. b Base
Excess (BE) by the time of arrival in the emergency department
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patients in shock remained steady by the time of arrival
at the ED. However, improved BE at the time of admis-
sion at ED might indicate a better tissue perfusion des-
pite unaltered low BP. Apparently the decrease in
volume administered was potentially compensated by
catecholamines given to a greater extend. In trauma pa-
tients, the administration of catecholamines recruits un-
stressed blood volume and might maintain blood
pressure [27]. But despite numerous arguments in favour
of early vasopressor use, there is still a lack of evidence
derived from prospective studies [28]. Some authors
even associate vasopressor exposure with an increased
mortality [29, 30]. Since catecholamines might influence
the presented data masking a true intravascular volume
deficit, [31] we observed indeed a reduced extend of
hypovolemic shock, mirrored by the reduced BE by the
time of emergency admission [32]. However, the con-
tinuous reduction of BE interferes with the unaltered
rate of patients with systolic blood pressure below
90 mmHg. Although Eastridge et al. showed that mortal-
ity starts to increase with a systolic BP below 110mmHG
in patients without brain injury, we defined shock as a
BP below or equal 90 mmHg in order to include patients
in severe shock [33]. The question remains, if the defin-
ition of shock using solely the systolic blood pressure is
applicable in this study, although BE values are usually
not compiled preclinical.
As described in the current literature, inadequate volume
administration and endogenous factors such as tissue hypo-
perfusion, inflammation and the acute activation of the
neurohumoral system contribute to coagulopathy [21]. Al-
though it has been described that crystalloids given even in-
crease thrombin generation [34] and that low quick values
are not necessarily attend with diminished thrombin gener-
ation [35], minimizing the iatrogenic contribution to the
development of a TIC might have resulted in a higher
Quick’s value and shortened aPTT.
Furthermore, the use of haemostatic drugs increased
within the observation period. The administration of
Tranexamic Acid (TXA) within 3 h after injury signifi-
cantly reduced the all-cause mortality and in particular
due to bleeding [36]. Subsequently, an early prehospital
use of TXA is already recommended in the updated
European guidelines [17]. Nevertheless, benefits of pre-
hospital administration of TXA are widely lacking but a
prospective, blinded study is currently underway. The
study design was recently published scrutinizing this
issue [37].
A further target to avoid coagulopathy is discussed by
substitution of fibrinogen as fibrinogen depletes early after
trauma. The effect of prehospital fibrinogen concentrate
administration is the subject of an on-going prospective
investigation [38]. Since the results of these studies might
support the prehospital use of both, fibrinogen and TXA,
the administration of haemostatic drugs is likely to incline
within the next years.
The changes observed in volume therapy might have re-
duced haemodilution potentially resulting in an increase of
the Hb value, which might explain that in 2012 the number
of patients receiving blood products halved in comparison
to 2002. Correspondingly the percentage of patients receiv-
ing MT halved. Already Geeraedts et al. showed, that the
likelihood of receiving blood transfusion increases dramat-
ically associated with increasing prehospital volume [25].
Thereby, the development during the last years is certainly
along the right lines to avoid mass transfusions as blood
products may imply negative secondary effects, such as sin-
gle or multiple organ failure and sepsis [39, 40]. Besides vol-
ume administration, the decreasing rate of MT has
multiple reasons. Transfusion strategies have become more
restrictive and ratio based to avoid over transfusion and di-
minish negative effects caused by blood products [41, 42].
Furthermore the updated European guidelines recommend
a target-haemoglobin of not more than 7 to 9 g/dl (1c) [17].
In addition, high blood product ratios result in dilution of
coagulation factors and inhibitors, prolonged PTT and in-
creased INR and reduced functional coagulation in visco-
elastic testing [43]. The quantity of RBCs and FFPs
transfused nearly approached a 1:1 ratio, which reflects
principles of damage control resuscitation [44] and the rec-
ommendations of the current European guidelines [17].
However, the amount of FFPs transfused only declined
slightly.
Certainly as this study is a retrospective register ana-
lysis, there are limitations such as susceptibility to obser-
ver bias, bias because of selective survival information,
incomplete or inaccurate information and dependency
on respondents. Therefore, only associations and no
causalities can be derived from the underlying data. Still,
the TR-DGU® enables illustration of consistency or
changes in therapy or therapeutically actions.
Conclusion
The volume administered in severely injured patients
decreased considerably during the period observed. In
addition to an increased use of haemostatic drugs and
goal directed transfusion protocols the need for transfu-
sion is likely to decline further. Although having identi-
fied principal drivers of coagulopathy and implementing
evidence based algorithms, it still remains unclear, which
basic amount of pre-hospital volume therapy is needed.
Therefore, subsequent research is inevitable. Despite
outstanding questions, principle evidence in volume
management has rapidly merged into clinical practice
and algorithms during the last years.
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